{"filing":{"accession_number":"0001193125-26-281037","cik":"0001861795","ticker":"DH","company_name":"Definitive Healthcare Corp.","form":"8-K","filing_date":"2026-06-24","report_date":null,"primary_document":"dh-20260618.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526281037/dh-20260618.htm"},"events":[{"id":13483,"run_id":11981,"accession_number":"0001193125-26-281037","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Definitive Healthcare received written notice from Nasdaq on June 18, 2026, that it failed to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). The company has 180 calendar days until December 15, 2026, to regain compliance, with the explicit warning that failure to do so could result in delisting. This is a classic delisting-risk disclosure under Item 3.01.","company_name":"Definitive Healthcare Corp.","ticker":"DH","filing_date":"2026-06-24","form":"8-K","submitted_at":null,"items":[{"id":10625,"accession_number":"0001193125-26-281037","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Definitive Healthcare received written notice from Nasdaq on June 18, 2026, that it failed to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). The company has 180 calendar days until December 15, 2026, to regain compliance, with the explicit warning that failure to do so could result in delisting. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:07:38.755315+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10625,"accession_number":"0001193125-26-281037","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Definitive Healthcare received written notice from Nasdaq on June 18, 2026, that it failed to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). The company has 180 calendar days until December 15, 2026, to regain compliance, with the explicit warning that failure to do so could result in delisting. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:07:38.755315+00:00","company_name":"Definitive Healthcare Corp.","ticker":"DH","filing_date":"2026-06-24"}]}